On-Demand Webcasts

Share

Program Content

Activities

  • JAK Inhibitors as First Line Therapy in Myelofibrosis
    Modern JAKi Strategies in Individualized Myelofibrosis Management: Considerations for First-line Therapy
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 18, 2025

    Expires: September 17, 2025

  • JAK Inhibitors in Myelofibrosis as Second Line Therapy and Beyond
    Modern JAKi Strategies in Individualized Myelofibrosis Management: Current Practices for Second-line Therapy and Beyond
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 14, 2025

    Expires: September 13, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from CTI BioPharma Corp., a Sobi Company; and Incyte Corporation.

CTI BioPharma Corp., a Sobi Company

Incyte Corporation